Insights

Folic acid fortification of grains has significantly reduced neural tube defects like spina bifida and anencephaly. This public health initiative has led to approximately 920 fewer infant cases annually, demonstrating the effectiveness of mandated folic acid fortification.

Area of Science:

  • Public Health
  • Maternal and Child Health
  • Nutritional Epidemiology

Background:

  • Spina bifida and anencephaly are severe birth defects impacting neural tube development.
  • The U.S. Food and Drug Administration mandated folic acid fortification in enriched cereal grain products in 1998 to mitigate these defects.

Purpose of the Study:

  • To analyze trends in spina bifida and anencephaly prevalence in the United States from 1991 to 2001.
  • To assess the impact of folic acid fortification on the incidence of these neural tube defects.

Main Methods:

  • Utilized birth defect data reported to the National Center for Health Statistics (NCHS) from birth certificates (1991-2001).
  • Focused on live births in U.S. reporting areas, excluding Maryland, New Mexico, and New York for trend consistency.
  • Analyzed combined and individual prevalence data for spina bifida and anencephaly.

Main Results:

  • A significant decline of 23% in combined neural tube defects (spina bifida and anencephaly) was observed between 1996 and 2001.
  • Spina bifida prevalence decreased by 24%, and anencephaly by 21% during the same period.
  • These declines represent an estimated 920 infants annually born without these serious conditions.

Conclusions:

  • Folic acid fortification of enriched cereal grain products has demonstrably reduced the occurrence of spina bifida and anencephaly in the U.S.
  • Continued surveillance is crucial to monitor the long-term effectiveness of folic acid fortification programs.
  • The fortification policy represents a successful public health intervention for preventing major birth defects.

Related Concept Videos

Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...